Advertisement
Screener

Global Blood Therapeutics, Inc. Share-based Payment Arrangement, Expense

Global Blood Therapeutics, Inc. Share-based Payment Arrangement, Expense

Global Blood Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $19.84 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-08-08

  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $19.84M, a 0.64% decline year-over-year.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $19.14M, a 4.04% decline year-over-year.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $19.41M, a 0.15% increase year-over-year.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $18.08M, a 5.67% decline year-over-year.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $78.67M, a 10.06% increase from fiscal 2020.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $71.48M, a 56.57% increase from fiscal 2019.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2019 was $45.65M, a 51.77% increase from fiscal 2018.
  • Global Blood Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2018 was $30.08M, a 119.85% increase from fiscal 2017.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2022-06-30$19.84M
10-Q · filed 2022-08-08
$38.98M
10-Q · filed 2022-08-08
$58.39M
derived: sum of 3 quarters · filed 2022-08-08
$76.47M
derived: sum of 4 quarters · filed 2022-08-08
2022-03-31$19.14M
10-Q · filed 2022-05-04
$38.55M
derived: sum of 2 quarters · filed 2022-05-04
$56.63M
derived: sum of 3 quarters · filed 2022-05-04
$76.59M
derived: sum of 4 quarters · filed 2022-08-08
2021-12-31$19.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$37.48M
derived: sum of 2 quarters · filed 2022-02-23
$57.45M
derived: sum of 3 quarters · filed 2022-08-08
$78.67M
10-K · filed 2022-02-23
2021-09-30$18.08M
10-Q · filed 2021-11-04
$38.05M
derived: sum of 2 quarters · filed 2022-08-08
$59.26M
10-Q · filed 2021-11-04
$77.37M
derived: sum of 4 quarters · filed 2022-08-08
2021-06-30$19.97M
10-Q · filed 2022-08-08
$40.35M
10-Q · filed 2022-08-08
$59.30M
derived: sum of 3 quarters · filed 2022-08-08
$78.46M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$19.95M
10-Q · filed 2022-05-04
$39.33M
derived: sum of 2 quarters · filed 2022-05-04
$58.49M
derived: sum of 3 quarters · filed 2022-05-04
$75.06M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31$19.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$38.54M
derived: sum of 2 quarters · filed 2022-02-23
$55.11M
derived: sum of 3 quarters · filed 2022-02-23
$71.48M
10-K · filed 2022-02-23
2020-09-30$19.16M
10-Q · filed 2021-11-04
$35.73M
derived: sum of 2 quarters · filed 2021-11-04
$52.10M
10-Q · filed 2021-11-04
$64.90M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$16.57M
10-Q · filed 2021-08-03
$32.94M
10-Q · filed 2021-08-03
$45.73M
derived: sum of 3 quarters · filed 2022-02-23
$58.19M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$16.37M
10-Q · filed 2021-05-05
$29.16M
derived: sum of 2 quarters · filed 2022-02-23
$41.62M
derived: sum of 3 quarters · filed 2022-02-23
$52.56M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31$12.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$25.25M
derived: sum of 2 quarters · filed 2022-02-23
$36.20M
derived: sum of 3 quarters · filed 2022-02-23
$45.65M
10-K · filed 2022-02-23
2019-09-30$12.45M
10-Q · filed 2020-11-05
$23.40M
derived: sum of 2 quarters · filed 2020-11-05
$32.85M
10-Q · filed 2020-11-05
$40.38M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$10.95M
10-Q · filed 2020-08-05
$20.40M
10-Q · filed 2020-08-05
$27.93M
derived: sum of 3 quarters · filed 2021-02-24
$34.90M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$9.45M
10-Q · filed 2020-05-06
$16.98M
derived: sum of 2 quarters · filed 2021-02-24
$23.95M
derived: sum of 3 quarters · filed 2021-02-24
$31.75M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$7.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$14.50M
derived: sum of 2 quarters · filed 2021-02-24
$22.30M
derived: sum of 3 quarters · filed 2021-02-24
$30.08M
10-K · filed 2021-02-24
2018-09-30$6.97M
10-Q · filed 2019-11-07
$14.77M
derived: sum of 2 quarters · filed 2019-11-07
$22.55M
10-Q · filed 2019-11-07
$27.29M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$7.80M
10-Q · filed 2019-08-07
$15.58M
10-Q · filed 2019-08-07
$20.32M
derived: sum of 3 quarters · filed 2020-02-26
$24.03M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$7.78M
10-Q · filed 2019-05-10
$12.53M
derived: sum of 2 quarters · filed 2020-02-26
$16.23M
derived: sum of 3 quarters · filed 2020-02-26
$18.89M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$4.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$8.45M
derived: sum of 2 quarters · filed 2020-02-26
$11.11M
derived: sum of 3 quarters · filed 2020-02-26
$13.68M
10-K · filed 2020-02-26
2017-09-30$3.71M
10-Q · filed 2018-11-06
$6.37M
derived: sum of 2 quarters · filed 2018-11-06
$8.94M
10-Q · filed 2018-11-06
$12.29M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$2.66M
10-Q · filed 2018-08-02
$5.23M
10-Q · filed 2018-08-02
$8.59M
derived: sum of 3 quarters · filed 2019-02-27
$11.74M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$2.57M
10-Q · filed 2018-05-07
$5.92M
derived: sum of 2 quarters · filed 2019-02-27
$9.08M
derived: sum of 3 quarters · filed 2019-02-27
$10.54M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$3.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$6.50M
derived: sum of 2 quarters · filed 2019-02-27
$7.97M
derived: sum of 3 quarters · filed 2019-02-27
$9.23M
10-K · filed 2019-02-27
2016-09-30$3.15M
10-Q · filed 2017-11-02
$4.62M
derived: sum of 2 quarters · filed 2017-08-07
$5.88M
10-Q · filed 2017-11-02
$7.38M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$1.47M
10-Q · filed 2017-08-07
$2.73M
10-Q · filed 2017-08-07
$4.22M
derived: sum of 3 quarters · filed 2018-02-27
$5.10M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$1.27M
10-Q · filed 2017-05-01
$2.76M
derived: sum of 2 quarters · filed 2018-02-27
$3.63M
derived: sum of 3 quarters · filed 2018-02-27
$4.17M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$2.37M
derived: sum of 2 quarters · filed 2018-02-27
$2.90M
derived: sum of 3 quarters · filed 2018-02-27
$3.22M
10-K · filed 2018-02-27
2015-09-30$874.00K
10-Q · filed 2016-11-09
$1.41M
derived: sum of 2 quarters · filed 2016-11-09
$1.73M
10-Q · filed 2016-11-09
$1.90M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$535.00K
10-Q · filed 2016-08-10
$857.00K
10-Q · filed 2016-08-10
$1.02M
derived: sum of 3 quarters · filed 2017-03-13
$1.11M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$322.00K
10-Q · filed 2016-05-12
$490.00K
derived: sum of 2 quarters · filed 2017-03-13
$576.00K
derived: sum of 3 quarters · filed 2017-03-13
$634.00K
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$254.00K
derived: sum of 2 quarters · filed 2017-03-13
$312.00K
derived: sum of 3 quarters · filed 2017-03-13
$350.00K
10-K · filed 2017-03-13
2014-09-30$86.00K
10-Q · filed 2015-11-12
$144.00K
derived: sum of 2 quarters · filed 2015-11-12
$182.00K
10-Q · filed 2015-11-12
2014-06-30$58.00K
10-Q · filed 2015-09-24
$96.00K
10-Q · filed 2015-09-24
2013-12-31$138.00K
10-K · filed 2016-03-29